These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6818656

  • 1. Clindamycin: a review of fifteen years of experience.
    Dhawan VK, Thadepalli H.
    Rev Infect Dis; 1982; 4(6):1133-53. PubMed ID: 6818656
    [Abstract] [Full Text] [Related]

  • 2. Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.
    Schoutens E, Van Beers D, Yourassowsky E.
    Infection; 1974; 2(2):59-63. PubMed ID: 4367028
    [No Abstract] [Full Text] [Related]

  • 3. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA.
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [Abstract] [Full Text] [Related]

  • 4. Clindamycin and gentamicin for aerobic and anaerobic sepsis.
    Fass RJ, Ruiz DE, Gardner WG, Rotilie CA.
    Arch Intern Med; 1977 Jan; 137(1):28-38. PubMed ID: 318824
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic resistance in anaerobic bacteria: molecular biology and clinical aspects.
    Bawdon RE, Crane LR, Palchaudhuri S.
    Rev Infect Dis; 1982 Jan; 4(6):1075-95. PubMed ID: 6760336
    [Abstract] [Full Text] [Related]

  • 6. Clindamycin plus gentamicin as expectant therapy for presumed mixed infections.
    Chow AW, Ota JK, Guze LB.
    Can Med Assoc J; 1976 Dec 18; 115(12):1225-9. PubMed ID: 1000457
    [Abstract] [Full Text] [Related]

  • 7. Interaction between penicillin, clindamycin or metronidazole and gentamicin against species of clostridia and anaerobic and facultatively anaerobic gram-positive cocci.
    Brook I, Walker RI.
    J Antimicrob Chemother; 1985 Jan 18; 15(1):31-7. PubMed ID: 3972757
    [Abstract] [Full Text] [Related]

  • 8. Lincomycin and clindamycin: their role in chemotherapy of anaerobic and microaerophilic infections.
    Savage GM.
    Infection; 1974 Jan 18; 2(3):152-9. PubMed ID: 4606764
    [No Abstract] [Full Text] [Related]

  • 9. In vitro antibacterial activity of the combination of clindamycin and ceftazidime.
    George WL.
    Antimicrob Agents Chemother; 1984 May 18; 25(5):657-8. PubMed ID: 6375564
    [Abstract] [Full Text] [Related]

  • 10. Antibiotic-impregnated heart valve sewing rings for treatment and prophylaxis of bacterial endocarditis.
    Cimbollek M, Nies B, Wenz R, Kreuter J.
    Antimicrob Agents Chemother; 1996 Jun 18; 40(6):1432-7. PubMed ID: 8726015
    [Abstract] [Full Text] [Related]

  • 11. Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria.
    Rahimi A, Martin WJ, Washington JA.
    Am J Clin Pathol; 1974 Sep 18; 62(3):425-7. PubMed ID: 4496770
    [No Abstract] [Full Text] [Related]

  • 12. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I.
    Surg Gynecol Obstet; 1987 Dec 18; 165(6):491-5. PubMed ID: 3317944
    [Abstract] [Full Text] [Related]

  • 13. Lincomycin, clindamycin and their applications.
    Spízek J, Rezanka T.
    Appl Microbiol Biotechnol; 2004 May 18; 64(4):455-64. PubMed ID: 14762701
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA, Fasching CE, Sinn LM, Gerding DN, Peterson LR.
    J Lab Clin Med; 1990 Feb 18; 115(2):190-5. PubMed ID: 1967626
    [Abstract] [Full Text] [Related]

  • 15. Treatment of anaerobic pulmonary infections; carbenicillin compared to clindamycin and gentamicin.
    Thadepalli H, Niden AH, Huang JT.
    Chest; 1976 Jun 18; 69(6):743-6. PubMed ID: 1277892
    [Abstract] [Full Text] [Related]

  • 16. Activity of ceftizoxime and comparative compounds against Bacteroides fragilis in a mouse model of anaerobic infection.
    Grappel SF, Phillips L, Actor P.
    J Antibiot (Tokyo); 1984 Apr 18; 37(4):384-8. PubMed ID: 6327593
    [Abstract] [Full Text] [Related]

  • 17. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I.
    J Med Microbiol; 1988 Nov 18; 27(3):191-8. PubMed ID: 2903934
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antimicrobial activity of clindamycin analogues: pirlimycin, 1,2 a potent antibacterial agent.
    Birkenmeyer RD, Kroll SJ, Lewis C, Stern KF, Zurenko GE.
    J Med Chem; 1984 Feb 18; 27(2):216-23. PubMed ID: 6363698
    [Abstract] [Full Text] [Related]

  • 19. Lincomycin. 14. An improved synthesis and resolution of the antimalarial agent, 1'-demethyl-4'-depropyl-4'-(R)- and -(S)-pentylclindamycin hydrochloride (U-24, 729A).
    Magerlein BJ.
    J Med Chem; 1972 Dec 18; 15(12):1255-9. PubMed ID: 4629012
    [No Abstract] [Full Text] [Related]

  • 20. [Lincosamide antibiotics].
    Vacek V.
    Cas Lek Cesk; 1991 Dec 27; 130(26):715-22. PubMed ID: 1806241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.